نتائج البحث - "Swanson, Chad J"

1

Academic Journal

المؤلفون: van Dyck, Christopher H, Swanson, Chad J, Aisen, Paul, Bateman, Randall J, Chen, Christopher, Gee, Michelle, Kanekiyo, Michio, Li, David, Reyderman, Larisa, Cohen, Sharon, Froelich, Lutz, Katayama, Sadao, Sabbagh, Marwan, Vellas, Bruno, Watson, David, Dhadda, Shobha, Irizarry, Michael, Kramer, Lynn D, Iwatsubo, Takeshi

المصدر: Neurology

مصطلحات موضوعية: Humans, Activities of Daily Living, Alzheimer Disease (diagnostic imaging, drug therapy), Amyloid beta-Peptides (cerebrospinal fluid), Antibodies, Monoclonal, Humanized (adverse effects, pharmacology, therapeutic use), Cognition (drug effects), Double-Blind Method, Nootropic Agents (adverse effects

Relation: https://scholar.barrowneuro.org/neurology/1476; https://doi.org/10.1056/NEJMoa2212948

الاتاحة: https://scholar.barrowneuro.org/neurology/1476
https://doi.org/10.1056/NEJMoa2212948

View record in BASE

2

Academic Journal

ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease

المؤلفون: Honig, Lawrence S, Barakos, Jerome, Dhadda, Shobha, Kanekiyo, Michio, Reyderman, Larisa, Irizarry, Michael, Kramer, Lynn D, Swanson, Chad J, Sabbagh, Marwan

المصدر: Neurology

مصطلحات موضوعية: ARIA, Alzheimer's disease, anti‐amyloid, exposure response modeling, lecanemab

Relation: https://scholar.barrowneuro.org/neurology/1463; https://doi.org/10.1002/trc2.12377

الاتاحة: https://scholar.barrowneuro.org/neurology/1463
https://doi.org/10.1002/trc2.12377

View record in BASE

3

Academic Journal

The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

المؤلفون: Rafii, Michael S., Sperling, Reisa A., Donohue, Michael C., Zhou, Jin, Roberts, Claire, Irizarry, Michael C., Dhadda, Shobha, Sethuraman, Gopalan, Kramer, Lynn D, Swanson, Chad J, Li, David, Krause, Stephen, Rissman, Robert A., Walter, Sarah, Raman, Rema, Johnson, Keith A., Aisen, Paul S.

المصدر: Alzheimer's & Dementia ; volume 19, issue 4, page 1227-1233 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.12748
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12748
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.12748

View record in BASE

4

Academic Journal

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease

المؤلفون: Dhadda, Shobha, Kanekiyo, Michio, Li, David, Swanson, Chad J., Irizarry, Michael, Berry, Scott, Kramer, Lynn D., Berry, Donald A.

المصدر: Alzheimer's Research & Therapy ; volume 14, issue 1 ; ISSN 1758-9193

الاتاحة: http://dx.doi.org/10.1186/s13195-022-01129-x
https://link.springer.com/content/pdf/10.1186/s13195-022-01129-x.pdf
https://link.springer.com/article/10.1186/s13195-022-01129-x/fulltext.html

View record in BASE

5

Academic Journal

Correction: A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

المؤلفون: Swanson, Chad J., Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y. K., Lannfelt, Lars, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A., Berry, Scott, Gordon, Robert, Kramer, Lynn D., Cummings, Jeffrey L.

المصدر: Alzheimer's Research & Therapy ; volume 14, issue 1 ; ISSN 1758-9193

الاتاحة: https://doi.org/10.1186/s13195-022-00995-9
https://link.springer.com/content/pdf/10.1186/s13195-022-00995-9.pdf
https://link.springer.com/article/10.1186/s13195-022-00995-9/fulltext.html

View record in BASE

6

Academic Journal

Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

المؤلفون: McDade, Eric, Cummings, Jeffrey L., Dhadda, Shobha, Swanson, Chad J., Reyderman, Larisa, Kanekiyo, Michio, Koyama, Akihiko, Irizarry, Michael, Kramer, Lynn D., Bateman, Randall J.

المصدر: Alzheimer's Research & Therapy ; volume 14, issue 1 ; ISSN 1758-9193

الاتاحة: http://dx.doi.org/10.1186/s13195-022-01124-2
https://link.springer.com/content/pdf/10.1186/s13195-022-01124-2.pdf
https://link.springer.com/article/10.1186/s13195-022-01124-2/fulltext.html

View record in BASE

7

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-A beta protofibril antibody

المؤلفون: Swanson, Chad J., Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y. K., Lannfelt, Lars, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A., Berry, Scott, Gordon, Robert, Kramer, Lynn D., Cummings, Jeffrey L.

المصدر: Alzheimer's Research & Therapy. 13

مصطلحات موضوعية: Alzheimer's disease, Amyloid, Lecanemab, BAN2401, Clinical trial, Biomarker, ADCOMS, Amyloid PET, Neurofilament light, Neurogranin, p-tau

وصف الملف: electronic

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-442519
https://doi.org/10.1186/s13195-021-00813-8
https://uu.diva-portal.org/smash/get/diva2:1554708/FULLTEXT01.pdf

View record in SwePub

8

Academic Journal

A Randomized, Double-Blind, Phase 2b Proof-of-Concept Clinical Trial in Early Alzheimer’s Disease With Lecanemab, an Anti-aβ Protofibril Antibody

المؤلفون: Swanson, Chad J., Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Lai, Robert Y.K., Lannfelt, Lars, Bradley, Heather, Rabe, Martin, Koyama, Akihiko, Reyderman, Larisa, Berry, Donald A., Berry, Scott, Gordon, Robert, Kramer, Lynn D., Cummings, Jeffrey L.

المصدر: School of Medicine Faculty Publications

مصطلحات موضوعية: ADCOMS, Alzheimer’s disease, Amyloid, Amyloid PET, BAN2401, Biomarker, Clinical trial, Lecanemab, Neurofilament light, Neurogranin, p-tau, Cognitive Neuroscience

وصف الملف: application/pdf

Relation: https://digitalscholarship.unlv.edu/som_fac_articles/626; https://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1625&context=som_fac_articles

الاتاحة: https://digitalscholarship.unlv.edu/som_fac_articles/626
https://digitalscholarship.unlv.edu/cgi/viewcontent.cgi?article=1625&context=som_fac_articles

View record in BASE

9

Academic Journal

Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease

المؤلفون: Lynch, Shau Yu, Irizarry, Michael C, Dhadda, Shobha, Li, David JianJun, Kanekiyo, Michio, Bogoslovsky, Tanya, Gee, Michelle, Reyderman, Larisa, Kaplow, June, Rabe, Martin, Hodgkinson, Mark, Kramer, Lynn D, Hampel, Harald, Swanson, Chad J

المصدر: Alzheimer's & Dementia ; volume 17, issue S9 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.054331
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.054331

View record in BASE

10

Academic Journal

AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial) ; Clinical trial design and implementation

المؤلفون: Aisen, Paul S., Zhou, Jin, Irizarry, Michael C., Kramer, Lynn D, Swanson, Chad J., Dhadda, Shobha, Rabe, Martin, Krause, Stephen, Li, David JianJun, Raman, Rema, Donohue, Michael C., Sethuraman, Gopalan, Johnson, Keith A., Sperling, Reisa A.

المصدر: Alzheimer's & Dementia ; volume 16, issue S9 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.044511
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.044511

View record in BASE

11

Academic Journal

A preliminary account of ARIA‐E in the ongoing open‐label extension phase of BAN2401‐G000‐201 in subjects with early Alzheimer’s disease ; Human/Human trials: Anti‐amyloid

المؤلفون: Swanson, Chad J., Lai, Robert Y.K., Bogoslovsky, Tanya, Bradley, Heather, Rabe, Martin, Zhang, Yong, Kramer, Lynn D.

المصدر: Alzheimer's & Dementia ; volume 16, issue S9 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.046059
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.046059

View record in BASE

12

Academic Journal

A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer’s disease ; Human/Human trials: Anti‐amyloid

المؤلفون: Swanson, Chad J., Zhang, Yong, Dhadda, Shobha, Wang, Jinping, Kaplow, June, Bradley, Heather, Rabe, Martin, Lai, Robert Y.K., Gordon, Robert, Kramer, Lynn D.

المصدر: Alzheimer's & Dementia ; volume 16, issue S9 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.046209
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.046209

View record in BASE

13

Academic Journal

P4‐657: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC ANALYSES OF BAN2401 IN PATIENTS WITH EARLY ALZHEIMER'S DISEASE: CORRELATION OF BAN2401 EXPOSURE, PET STANDARD UPTAKE VALUE RATIO, AND COGNITIVE OUTCOMES

المؤلفون: Schuck, Edgar L., Reyderman, Larisa, Hayato, Seiichi, Takenaka, Osamu, Swanson, Chad J., Lai, Robert YK., Hussein, Ziad, Ferry, Jim

المصدر: Alzheimer's & Dementia ; volume 15, issue 7S_Part_30 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1016/j.jalz.2019.09.023
https://api.elsevier.com/content/article/PII:S1552526019353956?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1552526019353956?httpAccept=text/plain
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2019.09.023
http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.jalz.2019.09.023/fullpdf

View record in BASE

14

Academic Journal

DT‐01‐01: BAN2401 IN EARLY ALZHEIMER'S DISEASE: NEURODEGENERATION BIOMARKER ANALYSIS FROM A RANDOMIZED PHASE 2 STUDY

المؤلفون: Molinuevo, Jose Luis, Koyama, Akihiko, Dhadda, Shobha, Irizarry, Michael C., Swanson, Chad J., Zhang, Yong, Kaplow, June, Bradley, Heather, Rabe, Martin, Totsuka, Keiichiro, Lai, Robert YK., Gordon, Robert, Kramer, Lynn D.

المصدر: Alzheimer's & Dementia ; volume 15, issue 7S_Part_28 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1016/j.jalz.2019.08.004
https://api.elsevier.com/content/article/PII:S1552526019351635?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1552526019351635?httpAccept=text/plain
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.jalz.2019.08.004
http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.jalz.2019.08.004/fullpdf

View record in BASE

15

Academic Journal

Lecanemab for Patients With Early Alzheimer Disease ; Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial

المؤلفون: Berry, Donald A., Dhadda, Shobha, Kanekiyo, Michio, Li, David, Swanson, Chad J., Irizarry, Michael, Kramer, Lynn D., Berry, Scott M.

المصدر: JAMA Network Open ; volume 6, issue 4, page e237230 ; ISSN 2574-3805

الاتاحة: http://dx.doi.org/10.1001/jamanetworkopen.2023.7230
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2803673/berry_2023_oi_230237_1680623485.62644.pdf

View record in BASE

16

Additional file 1 of Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

المؤلفون: McDade, Eric, Cummings, Jeffrey L., Dhadda, Shobha, Swanson, Chad J., Reyderman, Larisa, Kanekiyo, Michio, Koyama, Akihiko, Irizarry, Michael, Kramer, Lynn D., Bateman, Randall J.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ac53a152a7c46210c12dcfa99c955ea

View record in OpenAIRE

17

Academic Journal

Neuropathological autopsy findings in an individual with Alzheimer’s disease who received long‐term treatment with lecanemab (BAN2401)

المؤلفون: Honig, Lawrence S, Sun, Yu, Irizarry, Michael C, Swanson, Chad J, Dhadda, Shobha, Charil, Arnaud, Hart, David E, Noble, James M, Huey, Edward D, Teich, Andrew F

المصدر: Alzheimer's & Dementia ; volume 18, issue S10 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.069220
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.069220
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/alz.069220

View record in BASE

18

Academic Journal

Lecanemab (BAN2401) Infusion Reactions and Immunogenicity: Results from Randomized Phase 2 Study and an Open‐Label Extension (OLE).

المؤلفون: Landry, Ishani, Kanekiyo, Michio, Aluri, Jagadeesh, Li, David JianJun, Hussein, Ziad, Reyderman, Larisa, Dhadda, Shobha, Swanson, Chad J, Irizarry, Michael C, Kramer, Lynn D

المصدر: Alzheimer's & Dementia ; volume 18, issue S10 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.066289
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.066289

View record in BASE

19

Academic Journal

Subcutaneous Dose Selection of Lecanemab for Treatment of Subjects with Early Alzheimer’s Disease (EAD)

المؤلفون: Hayato, Seiichi, Rawal, Sumit, Takenaka, Osamu, Landry, Ishani, Boyd, Peter, Aluri, Jagadeesh, Willis, Brian A, Swanson, Chad J, Yasuda, Sanae, Hussein, Ziad, Reyderman, Larisa

المصدر: Alzheimer's & Dementia ; volume 18, issue S10 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.069429
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.069429

View record in BASE

20

Academic Journal

Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Lecanemab in Healthy Subjects

المؤلفون: Rawal, Sumit, Duong, Anh, Landry, Ishani, Aluri, Jagadeesh, Boyd, Peter, Yagi, Takuya, Swanson, Chad J, Reyderman, Larisa

المصدر: Alzheimer's & Dementia ; volume 18, issue S10 ; ISSN 1552-5260 1552-5279

الاتاحة: http://dx.doi.org/10.1002/alz.069438
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.069438

View record in BASE

تنقيح النتائج